1. Home
  2. RNAZ vs INTZ Comparison

RNAZ vs INTZ Comparison

Compare RNAZ & INTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNAZ
  • INTZ
  • Stock Information
  • Founded
  • RNAZ 2016
  • INTZ 1983
  • Country
  • RNAZ United States
  • INTZ United States
  • Employees
  • RNAZ N/A
  • INTZ N/A
  • Industry
  • RNAZ Biotechnology: Pharmaceutical Preparations
  • INTZ Computer Communications Equipment
  • Sector
  • RNAZ Health Care
  • INTZ Telecommunications
  • Exchange
  • RNAZ Nasdaq
  • INTZ Nasdaq
  • Market Cap
  • RNAZ 4.9M
  • INTZ 4.9M
  • IPO Year
  • RNAZ 2021
  • INTZ 2020
  • Fundamental
  • Price
  • RNAZ $3.84
  • INTZ $0.45
  • Analyst Decision
  • RNAZ Strong Buy
  • INTZ Buy
  • Analyst Count
  • RNAZ 1
  • INTZ 2
  • Target Price
  • RNAZ $99.00
  • INTZ $6.00
  • AVG Volume (30 Days)
  • RNAZ 30.4K
  • INTZ 262.1K
  • Earning Date
  • RNAZ 11-14-2024
  • INTZ 11-12-2024
  • Dividend Yield
  • RNAZ N/A
  • INTZ N/A
  • EPS Growth
  • RNAZ N/A
  • INTZ N/A
  • EPS
  • RNAZ N/A
  • INTZ N/A
  • Revenue
  • RNAZ N/A
  • INTZ $5,461,000.00
  • Revenue This Year
  • RNAZ N/A
  • INTZ $9.53
  • Revenue Next Year
  • RNAZ $233.33
  • INTZ $49.46
  • P/E Ratio
  • RNAZ N/A
  • INTZ N/A
  • Revenue Growth
  • RNAZ N/A
  • INTZ N/A
  • 52 Week Low
  • RNAZ $6.31
  • INTZ $0.43
  • 52 Week High
  • RNAZ $264.00
  • INTZ $5.40
  • Technical
  • Relative Strength Index (RSI)
  • RNAZ 23.15
  • INTZ 28.40
  • Support Level
  • RNAZ $6.63
  • INTZ $0.43
  • Resistance Level
  • RNAZ $8.46
  • INTZ $0.63
  • Average True Range (ATR)
  • RNAZ 1.04
  • INTZ 0.04
  • MACD
  • RNAZ -0.25
  • INTZ -0.01
  • Stochastic Oscillator
  • RNAZ 1.65
  • INTZ 14.95

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a clinical-stage oncology company focused on treating metastatic disease. It is committed to defeating cancer through the intelligent design and effective delivery of RNA therapeutics based on its proprietary TTX nanoparticle platform. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic tumors which overexpress microRNA-10b, a unique, well-documented biomarker of metastasis. In addition, TransCode is developing a portfolio of first-in-class RNA therapeutic candidates designed to overcome the challenges of RNA delivery and thus unlock therapeutic access to a variety of novel genetic targets that could be relevant to treating a variety of cancers.

About INTZ Intrusion Inc.

Intrusion Inc is a cybersecurity company based in Plano, Texas. It is engaged in developing, marketing, and supporting a group of entity identification, high-speed data mining, cybercrime, and persistent threat detection products. The company's product consists of TraceCop which is for identity discovery and disclosure, Savant for network data mining and persistent threat detection, and Compliance Commander which is for regulated information and data privacy protection. In addition, its products are used by various customers including banks, credit unions, other financial institutions, United States federal government entities, foreign government entities, hospitals, and other healthcare providers.

Share on Social Networks: